This is a Validated Antibody Database (VAD) review about pig VDR, based on 8 published articles (read how Labome selects the articles), using VDR antibody in all methods. It is aimed to help Labome visitors find the most suited VDR antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
VDR synonym: NR1I1; vitamin D3 receptor; 1,25-dihydroxyvitamin D3 receptor; nuclear receptor subfamily 1 group I member 1; vitamin D (1,25- dihydroxyvitamin D3) receptor

Invitrogen
rat monoclonal (9A7)
  • immunohistochemistry; human; loading ...; fig 1a
In order to measure breast vitamin D receptor expression and correlate its expression with tumor characteristics and patient survival, Invitrogen VDR antibody (ThermoFisher, MA1-710) was used in immunohistochemistry on human samples (fig 1a). Clin Cancer Res (2017) ncbi
rat monoclonal (9A7gamma.E10.E4)
  • western blot; human; 1:1000; fig 1
In order to characterize androgen receptor-targeted and vitamin D therapy for triple-negative breast cancer, Invitrogen VDR antibody (Thermofisher, MA5-14617) was used in western blot on human samples at 1:1000 (fig 1). Breast Cancer Res Treat (2016) ncbi
rat monoclonal (9A7)
  • western blot; human; fig 3
In order to determine the role of diet-derived 25-hydroxyvitamin D3 and suppressionof EGFR mutant non-small cell lung cancer growth in vitro and in vivo, Invitrogen VDR antibody (Thermo Scientific, MA1-710) was used in western blot on human samples (fig 3). Oncotarget (2016) ncbi
rat monoclonal (9A7)
  • immunohistochemistry - paraffin section; mouse; 1:250; fig 2d
In order to test if vitamin D is protective in the N-nitroso-tris-chloroethylurea mouse model, Invitrogen VDR antibody (Affinity Bio, MA1-710) was used in immunohistochemistry - paraffin section on mouse samples at 1:250 (fig 2d). Cancer Prev Res (Phila) (2015) ncbi
rat monoclonal (9A7)
  • western blot; mouse; fig 6.a,b
In order to study UL97-mediated retinoblastoma phosphorylation, Invitrogen VDR antibody (Thermo Fisher Scientific, 9A7) was used in western blot on mouse samples (fig 6.a,b). J Biol Chem (2015) ncbi
rat monoclonal (9A7)
  • immunohistochemistry - paraffin section; mouse; fig 3
  • western blot; mouse
In order to assess the impact of 1,25(OH)2D3 on the chemopreventive efficacy of erlotinib against head and neck squamous cell carcinomas, Invitrogen VDR antibody (Thermo Fisher Scientific, MA1-710) was used in immunohistochemistry - paraffin section on mouse samples (fig 3) and in western blot on mouse samples . Cancer Prev Res (Phila) (2015) ncbi
rat monoclonal (9A7)
  • chromatin immunoprecipitation; mouse
  • western blot; mouse; 1:500
In order to investigate the relationship between vitamin D and parathyroid hormone signaling during skeletal development, Invitrogen VDR antibody (Affinity Bioreagents, MA1-710) was used in chromatin immunoprecipitation on mouse samples and in western blot on mouse samples at 1:500. J Cell Physiol (2014) ncbi
rat monoclonal (9A7)
  • western blot; human; 1:200
In order to assess the effects of a novel Gemini vitamin D analog on breast cancer progression, Invitrogen VDR antibody (Thermoscientific, MA1-710) was used in western blot on human samples at 1:200. Cancer Prev Res (Phila) (2014) ncbi
Articles Reviewed
  1. Al Azhri J, Zhang Y, Bshara W, Zirpoli G, McCann S, Khoury T, et al. Tumor Expression of Vitamin D Receptor and Breast Cancer Histopathological Characteristics and Prognosis. Clin Cancer Res. 2017;23:97-103 pubmed publisher
  2. Thakkar A, Wang B, Picon Ruiz M, Buchwald P, Ince T. Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer. Breast Cancer Res Treat. 2016;157:77-90 pubmed publisher
  3. Verone Boyle A, Shoemaker S, Attwood K, Morrison C, Makowski A, Battaglia S, et al. Diet-derived 25-hydroxyvitamin D3 activates vitamin D receptor target gene expression and suppresses EGFR mutant non-small cell lung cancer growth in vitro and in vivo. Oncotarget. 2016;7:995-1013 pubmed publisher
  4. Mazzilli S, Hershberger P, Reid M, Bogner P, Atwood K, Trump D, et al. Vitamin D Repletion Reduces the Progression of Premalignant Squamous Lesions in the NTCU Lung Squamous Cell Carcinoma Mouse Model. Cancer Prev Res (Phila). 2015;8:895-904 pubmed publisher
  5. Iwahori S, Hakki M, Chou S, Kalejta R. Molecular Determinants for the Inactivation of the Retinoblastoma Tumor Suppressor by the Viral Cyclin-dependent Kinase UL97. J Biol Chem. 2015;290:19666-80 pubmed publisher
  6. Bothwell K, Shaurova T, Merzianu M, Suresh A, Kuriakose M, Johnson C, et al. Impact of Short-term 1,25-Dihydroxyvitamin D3 on the Chemopreventive Efficacy of Erlotinib against Oral Cancer. Cancer Prev Res (Phila). 2015;8:765-76 pubmed publisher
  7. Bach F, Rutten K, Hendriks K, Riemers F, Cornelissen P, de Bruin A, et al. The paracrine feedback loop between vitamin D? (1,25(OH)?D?) and PTHrP in prehypertrophic chondrocytes. J Cell Physiol. 2014;229:1999-2014 pubmed publisher
  8. Wahler J, So J, Kim Y, Liu F, Maehr H, Uskokovic M, et al. Inhibition of the transition of ductal carcinoma in situ to invasive ductal carcinoma by a Gemini vitamin D analog. Cancer Prev Res (Phila). 2014;7:617-26 pubmed publisher